Published: 2018-11-22

Articles

VALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION

Christina Hong, Shara Kim, Greg Curnew, Sam Schulman, Eleanor Pullenayegum, Anne Holbrook
Abstract 263 | PDF Downloads 147
PDF

THE RISE AND FALL OF THE THIAZOLIDINEDIONES: IMPACT OF CLINICAL EVIDENCE PUBLICATION AND FORMULARY CHANGE ON THE PRESCRIPTION INCIDENCE OF THIAZOLIDINEDIONES

Salman Hashim, Tara Gomes, David Juurlink, Chelsea Hellings, Muhammad Mamdani
Abstract 262 | PDF Downloads 146
PDF

Les Medicaments et la Sante Publique

sbryant sbryant
Abstract 184 | PDF Downloads 292
PDF

THERAPEUTIC DRUG MONITORING TO ASSESS CLINICAL RESPONSE TO SEDATIVE MEDICATIONS IN THE INTENSIVE CARE UNIT: A CASE REPORT AND DISCUSSION

Mahmoud Mosli, Daniel Ovakim, Rommel Tirona, George Dresser, Bandar Al-Judaibi
Abstract 194 | PDF Downloads 109
PDF

ODANACATIB DOES NOT INFLUENCE THE SINGLE DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN

S Aubrey Stoch, Rose Witter, David Hreniuk, Chengcheng Liu, Stefan Zajic, Anish Mehta, Patricia Chandler, Denise Morris, Hongwei Xue, Andrew Denker, John A Wagner
Abstract 290 | PDF Downloads 92
PDF

PHARMACOKINETICS IN REAL LIFE: SEX AND GENDER DIFFERENCES

Donald R Mattison
Abstract 529 | PDF Downloads 708
PDF

IMPACT OF PREGNANCY ON PHARMACOKINETICS OF MEDICATIONS

Mary F Hebert
Abstract 1814 | PDF Downloads 1015
PDF

SEX DEPENDENT PHARMACOKINETICS AND BIOEQUIVALENCE - TIME FOR CHANGE

Gideon Koren
Abstract 660 | PDF Downloads 308
PDF

GENDER BARRIERS IN POLICY AND REGULATION

Martha Nolan
Abstract 161 | PDF Downloads 101
PDF

CLINICAL PRACTICE GUIDELINE: CYP2D6 GENOTYPING FOR SAFE AND EFFICACIOUS CODEINE THERAPY

Parvaz Madadi, Ursula Amstutz, Michael Rieder, Shinya Ito, Vincent Fung, Soomi Hwang, Jacques Turgeon, Veronique Michaud, Gideon Koren, Bruce C Carleton
Abstract 2213 | PDF Downloads 689
PDF

MULTIPLE PRESCRIBERS IN OLDER FREQUENT OPIOID USERS – DOES IT MEAN ABUSE?

C Ineke Neutel, Svetlana Skurtveit, Christian Berg, Solveig Sakshaug
Abstract 228 | PDF Downloads 111
PDF

PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN

Anne M Holbrook, Eleanor M Pullenayegum, Sue M Troyan, Milica Nikitovic, Mark A Crowther
Abstract 195 | PDF Downloads 88
PDF

COMA, METABOLIC ACIDOSIS, AND METHEMOGLOBINEMIA IN A PATIENT WITH ACETAMINOPHEN TOXICITY

Hussein D Kanji, Shazma Mithani, Paul Boucher, Valerian C Dias, Mark C Yarema
Abstract 534 | PDF Downloads 308
PDF

SENSORY CONTROL OF BALANCE: A COMPARISON OF CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS TO CHILDREN WITH TYPICAL DEVELOPMENT

Tracy L Jirikowic, Sarah W McCoy, Anat Lubetzky-Vilnai, Robert Price, Marcia A Ciol, Deborah Kartin, Lin-Ya Hsu, Beth Gendler, Susan J Astley
Abstract 293 | PDF Downloads 99
PDF

FACE Poster Competition Abstracts - 14th Annual Meeting of the Fetal Alcohol Canadian Expertise (FACE) Research Association

St. John’s
Abstract 179 | PDF Downloads 99
PDF

CLINICAL CORRELATES OF FETAL ALCOHOL SPECTRUM DISORDER AMONG DIAGNOSED INDIVIDUALS IN A RURAL DIAGNOSTIC CLINIC

Mansfield Mela, Audrey McFarlane, Tolulope T Sajobi, Hasu Rajani
Abstract 502 | PDF Downloads 232
PDF

PHARMACOKINETICS OF ETHANOL IN THE MATERNAL-FETAL UNIT

Irene Zelner, Gideon Koren
Abstract 886 | PDF Downloads 653
PDF

ALCOHOL EXPOSURE AMONG PREGNANT WOMEN IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW

Celia L Culley, Tasha D Ramsey, Godfrey Mugyenyi, Gertrude N Kiwanuka, Joseph Ngonzi, Stuart MacLeod, Gideon Koren, Brian E Grunau, Matthew O Wiens
Abstract 864 | PDF Downloads 201
PDF

IDENTIFYING THE NEUROBEHAVIORAL PHENOTYPE OF FETAL ALCOHOL SPECTRUM DISORDER IN YOUNG CHILDREN

Petra Breiner, Irena Nulman, Gideon Koren
Abstract 772 | PDF Downloads 234
PDF

VALIDATION OF THE FETAL ALCOHOL SPECTRUM DISORDER (FASD) 4-DIGIT DIAGNOSTIC CODE

Susan J Astley
Abstract 1323 | PDF Downloads 524
PDF